EGFR and neoplasm: Normally, the EGFR/MAPK (mitogen-activated protein kinase) pathway is one of the major pathways driving tumor cell proliferation, whereas the activity of the PI3K pathway decreases due to the function of phosphatase and tensin homolog (PTEN).